Clariant reports November 3, 2026: CHF 0.68 forecast for Clariant stock

Published on 10/17/2026 at 22:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clariant's 52-week high was CHF 11.04 on August 14, 2026. Clariant stock costs CHF 10.61 on October 16, 2026, down 0.38 percent on SIX.

Reporting date and valuation

Clariant's third-quarter report is scheduled for November 3, 2026, with a CHF 0.68 2026 earnings-per-share forecast.
The stock's 52-week high was CHF 11.04 on August 14, 2026.
Clariant stock cost CHF 10.61 at SIX on October 16, 2026 at 5:31 p.m. CEST, down 0.38 percent versus the prior close of October 15, 2026.
Clariant had a market capitalization of CHF 3.5 billion and a P/E ratio of minus 106.10.

Clariant AG (CH0012142631) - Makro — Clariant AG (CH0012142631) in extremer Makro-Nahaufnahme mit scharfen Details und schmalem Schärfebereich, Illustration mit AI erstellt.

Clariant reports its third-quarter 2026 results on November 3, 2026, while a 2026 earnings-per-share forecast of CHF 0.68 was cited by finanzen.ch on October 15, 2026. Clariant stock was quoted at CHF 10.61 on the SIX on October 16, 2026 at 5:31 p.m. CEST, down 0.38 percent versus the prior close of October 15, 2026.

Results date sets the next checkpoint

The November 3 report is the next dated test for the expected earnings recovery. The scheduled date was also reported by Aktien und ETF on October 2, 2026. The same source placed Clariant's 52-week high at CHF 11.04 on August 14, 2026 and its 52-week low at CHF 6.55 on March 23, 2026.

Price position and trading range

At CHF 10.61, the stock stood CHF 0.43 below its 52-week high and CHF 4.06 above its 52-week low on October 16, 2026. The SIX session showed 439,761 shares traded, compared with an average volume of 948,437 shares. The bid and ask were not included in the same dated home-market quote.

Valuation and business scale

Clariant's market capitalization was CHF 3.5 billion on October 16, 2026, with a P/E ratio of minus 106.10 and a dividend yield of 0.04 percent. The company describes itself as a specialty chemicals group organized around Care Chemicals, Catalysts and Natural Resources, with 10,107 full-time employees. Its investor-relations page sets medium-term targets of 4.00 to 6.00 percent annual sales growth and a 19.00 to 21.00 percent EBITDA margin by 2027.

Comparison with peers

Clariant (SIX, CHF): minus 0.38 percent, P/E minus 106.10, market capitalization CHF 3.5 billion.

Evonik (Xetra, EUR): plus 0.47 percent, P/E 82.83, market capitalization EUR 10.0 billion.

Croda (LSE, GBp): plus 0.95 percent, P/E 64.06.

What the November date puts on the calendar

The November report should clarify whether Clariant's projected CHF 0.68 earnings per share for 2026 is supported by improving operations. The market picture remains mixed across the comparison lines, with Clariant's negative P/E reflecting its current earnings profile rather than a conventional profit multiple.

Clariant stock stood at CHF 10.61 on the SIX on October 16, 2026 at 5:31 p.m. CEST, down 0.38 percent versus the prior close of October 15, 2026.